Evolution of the Average Target: Ovintiv Inc.

Evolution of the Target Price: Ovintiv Inc.

Changes in Analyst Recommendations: Ovintiv Inc.

208be.5PxqpcxOH25ai3bH4AnOFE44KoplGx5FvJvZ2KuMCTA.j49d0oAJL1s370eE1H62Z3dQGd8TenAy2eHg6tHjZAaWjA_R-xl5OynFMw~64fd454073a67a6d78ec9792442b1429
Nov. 13 BMO Lowers Nuvista's Rating to Market Perform MT
Nov. 05 Ovintiv Maintained at Buy at UBS Following Third-Quarter Results; Price Target Kept at US$52.00 MT
Oct. 27 RBC Retains Ovintiv's Outperform Rating, US$55 Price Target MT
Oct. 16 Ovintiv Maintained at Buy at TPH Ahead of Third-Quarter Results; Price Target at US$56.00 MT
Oct. 15 Ovintiv Shares Rise After RBC Upgrade MT
Oct. 15 Ovintiv Upgraded to Outperform at RBC MT
Oct. 15 RBC Upgrades Ovintiv to Outperform From Sector Perform, Keeps $55 Price Target MT
Oct. 15 Analyst recommendations: JPMorgan, Alphabet, J&J, Sofi Tech, Vertiv Holdings… Zonebourse
Oct. 14 Roth Capital Partners Initiates Ovintiv at Neutral With $42 Price Target MT
Oct. 07 Ovintiv Maintained at Buy at UBS Ahead of Q3 Results; Price Target Kept at US$52.00 MT
Sep. 26 Ovintiv Sector Perform Rating and Target of US$55 Confirmed at RBC Following Investor Meeting MT
Aug. 20 UBS Adjusts Price Target on Ovintiv to $52 From $51, Maintains Buy Rating MT
Aug. 18 Morgan Stanley Downgrades Ovintiv to Equalweight From Overweight, Adjusts Price Target to $48 From $52 MT
Jul. 29 Ovintiv Maintained at Buy at UBS Following Q2 Results; Price Target Raised to US$51.00 MT
Jul. 29 Analyst recommendations: Blackstone, Airbnb, Amphenol, Cadence Design Systems, Ameriprise Financial... Zonebourse
Jul. 28 Ovintiv Maintained at Buy at TPH Following Q2 Results; Price Target at US$57.00 MT
Jul. 25 Ovintiv Maintained at Buy at UBS Following Q2 Results; Price Target Kept at US$43.00 MT
Jul. 25 Analyst recommendations: Thermo Fisher Scientific, Intel, Honeywell International, Union Pacific, Gilead Sciences... Zonebourse
Jul. 17 Analyst recommendations: JPMorgan, PayPal, Starbucks, Mattel, Twilio… Zonebourse
Jul. 01 Goldman Sachs Upgrades Ovintiv to Buy From Neutral, Adjusts Price Target to $47 From $51 MT
May. 07 Analyst recommendations: Skechers, Doordash, Stellantis, The Trade Desk, Yeti Holdings… Zonebourse
Mar. 24 UBS Cuts Ovintiv Price Target to $51 From $56, Maintains Buy Rating MT
Mar. 24 Ovintiv Upgraded to Outperform at BMO MT
Mar. 24 BMO Capital Upgrades Ovintiv to Outperform From Market Perform, Raises Price Target to $57 From $55 MT
Feb. 28 RBC Raises Price Target on Ovintiv to $55 From $53, Keeps Sector Perform Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+39.71%
-0.06%
+27.49%
+12.97%
+26.14%
+21.84%
+21.03%
+7.9%
+4.83%
+11.32%
Average +17.32%
Weighted average by Cap. +14.72%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
39.08USD
Average target price
53.37USD
Spread / Average Target
+36.56%
High Price Target
72.00USD
Spread / Highest target
+84.24%
Low Price Target
38.00USD
Spread / Lowest Target
-2.76%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Tudor Pickering Holt & Co.
RBC Capital Markets
Roth Capital Partners
Morgan Stanley
Goldman Sachs
BMO Capital
Barclays
Truist Securities
National Bank Financial
Evercore ISI
TD Cowen
Mizuho Securities
Citigroup
Wells Fargo Securities
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
39.08USD
Average target price
53.37USD
Spread / Average Target
+36.56%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. OVV Stock
  4. Consensus Ovintiv Inc.
BLACK FRIDAY 40% Discount: The Best Tools Reserved for Subscribers to Identify Your Next Winning Investment!
d
:
:
BENEFIT NOW